FDA Inspection 938949 — Jamaica Hospital Medical Center IRB

Jamaica Hospital Medical Center IRB — FEI 3011071528

The FDA completed an inspection of Jamaica Hospital Medical Center IRB on August 20, 2015 in Jamaica, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 20, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Jamaica, NY (United States)

Additional Details

IRB

Citations

IDCFRDescription
727621 CFR 56.107(c)One scientific and one non-scientific member
727721 CFR 56.107(d)One non-affiliate member
727821 CFR 56.107(e)Conflict of interest
728121 CFR 56.108(a)(1)Initial and continuing reviews
729021 CFR 56.108(c)Members present for review
731821 CFR 56.115(a)(2)Minutes of IRB meetings
733421 CFR 56.115(a)(5)List of members
733521 CFR 56.115(a)(6)Written procedures per 56.108(a) and (b)